{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:14:16Z","timestamp":1789820056265,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The level VI lymph nodes are anatomically connected to the level VII lymph nodes and papillary thyroid carcinoma (PTC) can metastasis to both regions. The aim of this study was to identify clinicopathologic factors associated with level VII lymph node metastasis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Between March 2015 and September 2016, a total of 275 consecutive patients were operated on for PTC with prophylactic level VII dissection at the Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, ZheJiang, China. Patients with PTC were performed via video-assisted approach. Multivariate logistic regression analysis was performed to evaluate the associations between clinicopathologic factors.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Of the 275 subjects enrolled in this study, 79 patients (28.73%) showed lymph node metastasis to the level VII. The multivariate logistic regression analysis showed ultrasonography-positive lymph nodes (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), the location of primary carcinoma (<jats:italic>p<\/jats:italic>\u2009=\u20090.002) and hashimoto thyroiditis (HT) (<jats:italic>p<\/jats:italic>\u2009=\u20090.04) were associated with level VII lymph node metastasis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Based on the results of our study, we considered central-compartment lymph node dissection (CLND) as an integral strategy. On the basis of surgery safety, transcervical level VII lymph node dissection could be considered for PTC patients with high risk factors such as ultrasonography-positive lymph nodes, tumor located in middle and lower thirds of the thyroid lobe and the patients without HT. In future, prognostic significance of level VII lymph node dissection should be evaluated through long-term surveillance.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12893-020-0675-5","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T17:03:12Z","timestamp":1579021392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Identifying risk factors for metastasis to the level VII lymph node in papillary thyroid carcinoma patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Jian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6854-9655","authenticated-orcid":false,"given":"Deguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"675_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1\u2013133.","journal-title":"Thyroid"},{"key":"675_CR2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0002-9343(94)90321-2","volume":"97","author":"EL Mazzaferri","year":"1994","unstructured":"Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418\u201328.","journal-title":"Am J Med"},{"key":"675_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00268-006-0722-0","volume":"31","author":"Y Ito","year":"2007","unstructured":"Ito Y, Miyauchi A. Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg. 2007;31:905\u201315.","journal-title":"World J Surg"},{"key":"675_CR4","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1089\/thy.2009.0159","volume":"19","author":"SE Carty","year":"2009","unstructured":"American Thyroid Association Surgery Working, Carty SE, Cooper DS, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009;19:1153\u20138.","journal-title":"Thyroid"},{"key":"675_CR5","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/00000658-195605000-00004","volume":"143","author":"GJ Crile","year":"1956","unstructured":"Crile GJ. The pattern of metastasis of carcinoma of the thyroid. Ann Surg. 1956;143:580\u20137.","journal-title":"Ann Surg"},{"key":"675_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1055-3207(18)30404-6","volume":"5","author":"SK Grebe","year":"1996","unstructured":"Grebe SK, Hay ID. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am. 1996;5:43\u201363.","journal-title":"Surg Oncol Clin N Am"},{"key":"675_CR7","first-page":"541","volume":"113","author":"A Sugenoya","year":"1993","unstructured":"Sugenoya A, Asanuma K, Shingu K, et al. Clinical evaluation of upper mediastinal dissection for differentiated thyroid carcinoma. Surgery. 1993;113:541\u20134.","journal-title":"Surgery"},{"key":"675_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1507\/endocrj.EJ15-0677","volume":"63","author":"S Moritani","year":"2016","unstructured":"Moritani S. Impact of superior mediastinal metastasis on the prognosis of papillary thyroid carcinoma. Endocr J. 2016;63:349\u201357.","journal-title":"Endocr J"},{"key":"675_CR9","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0002-9610(05)80710-X","volume":"164","author":"M Sellers","year":"1992","unstructured":"Sellers M, Beenken S, Blankenship A, et al. Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg. 1992;164:578\u201381.","journal-title":"Am J Surg"},{"key":"675_CR10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/cncr.21653","volume":"106","author":"CI Lundgren","year":"2006","unstructured":"Lundgren CI, Hall P, Dickman PW, et al. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer. 2006;106:524\u201331.","journal-title":"Cancer"},{"key":"675_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2265.2011.04162.x","volume":"76","author":"M Mulla","year":"2012","unstructured":"Mulla M. Central cervical lymph node metastases in papillary thyroid cancer: a systematic review of imaging-guided and prophylactic removal of the central compartment. Clin Endocrinol. 2012;76:131\u20136.","journal-title":"Clin Endocrinol"},{"key":"675_CR12","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1245\/s10434-012-2833-1","volume":"20","author":"LY Wang","year":"2013","unstructured":"Wang LY, Versnick MA, Gill AJ, et al. Level VII is an important component of central neck dissection for papillary thyroid cancer. Ann Surg Oncol. 2013;20:2261\u20135.","journal-title":"Ann Surg Oncol"},{"key":"675_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00268-001-0176-3","volume":"26","author":"A Machens","year":"2002","unstructured":"Machens A, Hinze R, Thomusch O, et al. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg. 2002;26:22\u20138.","journal-title":"World J Surg"},{"key":"675_CR14","doi-asserted-by":"publisher","first-page":"e0148420","DOI":"10.1371\/journal.pone.0148420","volume":"11","author":"JH Woo","year":"2016","unstructured":"Woo JH, Park KN, Lee JY, et al. Predictive factors of superior Mediastinal nodal metastasis from papillary thyroid carcinoma\u2014a prospective observational study. PLoS One. 2016;11:e0148420.","journal-title":"PLoS One"},{"key":"675_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.amjoto.2008.05.003","volume":"30","author":"Y Ducic","year":"2009","unstructured":"Ducic Y, Oxford L. Transcervical elective superior mediastinal dissection for thyroid carcinoma. Am J Otolaryngol. 2009;30:221\u20134.","journal-title":"Am J Otolaryngol"},{"key":"675_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00268-009-0303-0","volume":"34","author":"Y Ito","year":"2010","unstructured":"Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34:28\u201335.","journal-title":"World J Surg"},{"key":"675_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1507\/endocrj.K09E-025","volume":"56","author":"Y Ito","year":"2009","unstructured":"Ito Y, Fukushima M, Tomoda C, et al. Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. Endocr J. 2009;56:759\u201366.","journal-title":"Endocr J"},{"key":"675_CR18","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1210\/jc.2011-1546","volume":"97","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wei WJ, Ji QH, et al. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab. 2012;97:1250\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"675_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijsu.2016.02.093","volume":"28","author":"B Ma","year":"2016","unstructured":"Ma B, Wang Y, Yang S, et al. Predictive factors for central lymph node metastasis in patients with cN0 papillary thyroid carcinoma: a systematic review and meta-analysis. Int J Surg. 2016;28:153\u201361.","journal-title":"Int J Surg"},{"key":"675_CR20","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/hed.24568","volume":"39","author":"I Likhterov","year":"2017","unstructured":"Likhterov I, Reis LL, Urken ML. Central compaetment management in patients with papillary thyroid cancer presenting with metastatic disease to the lateral neck: anatomic pathways of lymphatic spread. Head Neck. 2017;39:853\u20139.","journal-title":"Head Neck"},{"key":"675_CR21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/archsurg.1955.01270080137023","volume":"70","author":"ME Dailey","year":"1955","unstructured":"Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg. 1955;70:291\u20137.","journal-title":"AMA Arch Surg"},{"key":"675_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/1471-2407-12-610","volume":"12","author":"L Zhang","year":"2012","unstructured":"Zhang L, Li H, Ji QH, et al. The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease. BMC Cancer. 2012;12:610.","journal-title":"BMC Cancer"},{"key":"675_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12022-010-9124-9","volume":"21","author":"HS Kim","year":"2010","unstructured":"Kim HS, Choi YJ, Yun JS. Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis. Endocr Pathol. 2010;21:149\u201353.","journal-title":"Endocr Pathol"},{"key":"675_CR24","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ng.339","volume":"4","author":"J Gudmundsson","year":"2009","unstructured":"Gudmundsson J, Sulem P, Gudbjartsson DF, et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet. 2009;4:460\u20134.","journal-title":"Nat Genet"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-020-0675-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12893-020-0675-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-020-0675-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:29:38Z","timestamp":1610497778000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-020-0675-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["675"],"URL":"https:\/\/doi.org\/10.1186\/s12893-020-0675-5","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"assertion":[{"value":"18 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethical Committee of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine gave approval for this study. All patients provided written informed consent for their information to be stored in the hospital database and used for study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this reports is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}